polycystic ovarian syndrom. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group: 20 mg Cimicifuga racimosa twice a day for 10 days with clomiphene citrate 50 mg twice a day for 5 days. The regimen will be started from the second day of the menst
Treatment - Drugs
Intervention group: 20 mg Cimicifuga racimosa twice a day for 10 days with clomiphene citrate 50 mg twice a day for 5 days. The regimen will be started from the second day of the menstrual cycle and w
Control group: clomiphene citrate 50 mg twice a day for 5 days. The regimen will be started from the second day of the menstrual cycle and will be prescribed for three consecutive cycles.
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 38 Years
Inclusion criteria
Inclusion criteria: Women with polycystic ovarian syndrome Primary and secondary infertility Normal hysterosalpingography Normal Spermogram in patients' spouses Age below 38 years
Exclusion criteria
Exclusion criteria: History of cardiovascular disease History of liver disease History Ovarian masses
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma estradiol. Timepoint: 12 days after intervention. Method of measurement: sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Endometrial thickness. Timepoint: 12 days after intervention. Method of measurement: sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMalihe Mahmoodo Nia
Mashhad University of Medical Sciences
Outcome results
None listed